Research ArticleArticle
Patient Preferences for Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review
Caylib Durand, Maysoon Eldoma, Deborah A. Marshall, Nick Bansback and Glen S. Hazlewood
The Journal of Rheumatology April 2019, jrheum.181165; DOI: https://doi.org/10.3899/jrheum.181165
Caylib Durand
From the Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Arthritis Research Canada; Centre for Health Evaluation and Outcome Sciences, Providence Health Care, St. Paul’s Hospital, Vancouver, British Columbia, Canada. The work was supported in part by a Canadian Initiative for Outcomes in Rheumatology Care grant and a Canadian Institute of Health Research (CIHR) grant (MOP - 142441). Dr. Hazlewood is supported by a CIHR New Investigator Salary Award and The Arthritis Society Young Investigator Salary Award. Dr. Marshall is supported by a CIHR Canada Research Chair in Health Services and Systems Research and the Arthur J.E. Child Chair of Rheumatology Outcomes Research. C. Durand, MD, PhD, FRCP(C), Rheumatology Fellow, University of Calgary; M. Eldoma, MD, FRCP(C), Rheumatology Fellow, University of Calgary; D.A. Marshall, Professor of Medicine, University of Calgary; N. Bansback, Associate Professor, University of British Columbia; G.S. Hazlewood, MD, PhD, FRCP(C), Assistant Professor, University of Calgary. Address correspondence to Dr. G.S. Hazlewood, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada. E-mail: gshazlew@ucalgary.ca. Accepted for publication April 1, 2019.
Maysoon Eldoma
From the Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Arthritis Research Canada; Centre for Health Evaluation and Outcome Sciences, Providence Health Care, St. Paul’s Hospital, Vancouver, British Columbia, Canada. The work was supported in part by a Canadian Initiative for Outcomes in Rheumatology Care grant and a Canadian Institute of Health Research (CIHR) grant (MOP - 142441). Dr. Hazlewood is supported by a CIHR New Investigator Salary Award and The Arthritis Society Young Investigator Salary Award. Dr. Marshall is supported by a CIHR Canada Research Chair in Health Services and Systems Research and the Arthur J.E. Child Chair of Rheumatology Outcomes Research. C. Durand, MD, PhD, FRCP(C), Rheumatology Fellow, University of Calgary; M. Eldoma, MD, FRCP(C), Rheumatology Fellow, University of Calgary; D.A. Marshall, Professor of Medicine, University of Calgary; N. Bansback, Associate Professor, University of British Columbia; G.S. Hazlewood, MD, PhD, FRCP(C), Assistant Professor, University of Calgary. Address correspondence to Dr. G.S. Hazlewood, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada. E-mail: gshazlew@ucalgary.ca. Accepted for publication April 1, 2019.
Deborah A. Marshall
From the Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Arthritis Research Canada; Centre for Health Evaluation and Outcome Sciences, Providence Health Care, St. Paul’s Hospital, Vancouver, British Columbia, Canada. The work was supported in part by a Canadian Initiative for Outcomes in Rheumatology Care grant and a Canadian Institute of Health Research (CIHR) grant (MOP - 142441). Dr. Hazlewood is supported by a CIHR New Investigator Salary Award and The Arthritis Society Young Investigator Salary Award. Dr. Marshall is supported by a CIHR Canada Research Chair in Health Services and Systems Research and the Arthur J.E. Child Chair of Rheumatology Outcomes Research. C. Durand, MD, PhD, FRCP(C), Rheumatology Fellow, University of Calgary; M. Eldoma, MD, FRCP(C), Rheumatology Fellow, University of Calgary; D.A. Marshall, Professor of Medicine, University of Calgary; N. Bansback, Associate Professor, University of British Columbia; G.S. Hazlewood, MD, PhD, FRCP(C), Assistant Professor, University of Calgary. Address correspondence to Dr. G.S. Hazlewood, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada. E-mail: gshazlew@ucalgary.ca. Accepted for publication April 1, 2019.
Nick Bansback
From the Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Arthritis Research Canada; Centre for Health Evaluation and Outcome Sciences, Providence Health Care, St. Paul’s Hospital, Vancouver, British Columbia, Canada. The work was supported in part by a Canadian Initiative for Outcomes in Rheumatology Care grant and a Canadian Institute of Health Research (CIHR) grant (MOP - 142441). Dr. Hazlewood is supported by a CIHR New Investigator Salary Award and The Arthritis Society Young Investigator Salary Award. Dr. Marshall is supported by a CIHR Canada Research Chair in Health Services and Systems Research and the Arthur J.E. Child Chair of Rheumatology Outcomes Research. C. Durand, MD, PhD, FRCP(C), Rheumatology Fellow, University of Calgary; M. Eldoma, MD, FRCP(C), Rheumatology Fellow, University of Calgary; D.A. Marshall, Professor of Medicine, University of Calgary; N. Bansback, Associate Professor, University of British Columbia; G.S. Hazlewood, MD, PhD, FRCP(C), Assistant Professor, University of Calgary. Address correspondence to Dr. G.S. Hazlewood, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada. E-mail: gshazlew@ucalgary.ca. Accepted for publication April 1, 2019.
Glen S. Hazlewood
From the Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Arthritis Research Canada; Centre for Health Evaluation and Outcome Sciences, Providence Health Care, St. Paul’s Hospital, Vancouver, British Columbia, Canada. The work was supported in part by a Canadian Initiative for Outcomes in Rheumatology Care grant and a Canadian Institute of Health Research (CIHR) grant (MOP - 142441). Dr. Hazlewood is supported by a CIHR New Investigator Salary Award and The Arthritis Society Young Investigator Salary Award. Dr. Marshall is supported by a CIHR Canada Research Chair in Health Services and Systems Research and the Arthur J.E. Child Chair of Rheumatology Outcomes Research. C. Durand, MD, PhD, FRCP(C), Rheumatology Fellow, University of Calgary; M. Eldoma, MD, FRCP(C), Rheumatology Fellow, University of Calgary; D.A. Marshall, Professor of Medicine, University of Calgary; N. Bansback, Associate Professor, University of British Columbia; G.S. Hazlewood, MD, PhD, FRCP(C), Assistant Professor, University of Calgary. Address correspondence to Dr. G.S. Hazlewood, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada. E-mail: gshazlew@ucalgary.ca. Accepted for publication April 1, 2019.
Data supplements
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Patient Preferences for Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review
Caylib Durand, Maysoon Eldoma, Deborah A. Marshall, Nick Bansback, Glen S. Hazlewood
The Journal of Rheumatology Apr 2019, jrheum.181165; DOI: 10.3899/jrheum.181165